Archive | In the News RSS feed for this section

The European Patent Office Changes the Rules for Filing Divisional Applications

In 2010, the European Patent Office (EPO) amended Rule 36 of the European Patent Convention to mandate that divisional applications could only be filed within two years after the first communication from the Examining Division of the EPO. After this two-year window, it was no longer possible to file divisional applications, except in extraordinary circumstances. […]

Comments Off on The European Patent Office Changes the Rules for Filing Divisional Applications Continue Reading →

Myriad Genetics Supreme Court decision, June 13, 2013

Assoc. for Molecular Path. et al. v. Myriad Genetics, Inc., No. 12-398 (U.S., June 13, 2013). The Supreme Court decided today that “[a] naturally occurring DNA segment is a product of nature and not patent eligible merely because it has been isolated” under 35 U.S.C. Section 101.  Therefore, naturally occurring DNA sequences containing both intron and […]

Comments Off on Myriad Genetics Supreme Court decision, June 13, 2013 Continue Reading →

Two Denver law firms win patent work from NIH: In the News

The Denver Business Journal profiles Swanson & Bratschun, LLC, who teamed with another firm to win a prestigious contract to handle biotechnology patents for the National Institutes of Health for 10 years. View the complete article as a PDF.

Comments Off on Two Denver law firms win patent work from NIH: In the News Continue Reading →

The Q Factor: In the News

Patent Ratings annual take on who prosecutes the highest-quality patents. Swanson & Bratschun, LLC received top honors in the Biotech category. View the complete article as a PDF.

Comments Off on The Q Factor: In the News Continue Reading →